November 30, 2023 — Johnson & Johnson MedTech1 today announced the completion of the acquisition2 of Laminar, Inc., a ...
Atrial Fibrillation
This channel includes news and new technology innovations for the treatment of atrial fibrillation, also referred to as AF or afib. AF is a cardiac arrhythmia caused by irregular and often rapid heart rate. It is caused by the upper chambers (the atria) beating irregularly and uncoordinated with the lower ventricle chambers of of the heart. Symptoms include weakness with heart palpitations and shortness of breath. The conditional can lead to an increased risk of stroke and heart failure. AF episodes can cause the blood in the atria to stagnate and form clots, usually within the left atrial appendage (LAA). The clots can flow to the brain and cause a stroke. Treatments include anticoagulation therapy to dissolve clots, catheter or surgical ablation and LAA occlusion.
November 24, 2023 — During the American Heart Association Scientific Sessions 2023, held recently in Philadephia, PA, Mi ...
For over a decade, the cardiac cryoablation industry has seen little in the way of technological advancements. Yet ...
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
November 10, 2023 — Cardiologists, cardiothoracic surgeons and interventionalists from the Smidt Heart Institute at ...
November 6, 2023 — Atrial fibrillation (AF) diagnosis was associated with a 45% increased risk of mild cognitive ...
In the United States, the options currently available for cardiac ablation use thermal mechanisms to ablate tissue and ...
For over a decade, the cardiac cryoablation industry has seen little in the way of technological advancements. Yet ...
October 25, 2023 — Findings from a trial led by Cleveland Clinic show that patients with atrial fibrillation undergoing ...
October 23, 2023 — Investigators from the Smidt Heart Institute at Cedars-Sinai found that an artificial intelligence (A ...
October 19, 2023 — Conformal Medical, Inc. announced today the one-year results from the company's CONFORMAL Early ...
In the United States, the options currently available for cardiac ablation use thermal mechanisms to ablate tissue and ...
October 9, 2023 — The vast majority of people who have a minimally invasive heart valve replacement procedure do not ...
October 6, 2023 — Biosense Webster, Inc., a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson ...
October 3, 2023 -- Boston Scientific launched the LUX-Dx II+ Insertable Cardiac Monitor (ICM) System, a next-generation ...
When the patients of Michael Boler, M.D. need cardiac monitoring, the Holter monitor is no longer his first choice. “The ...
September 26, 2023 — Anthos Therapeutics, Inc., a clinical stage company developing innovative therapies for ...
September 18, 2023 — Pregnant women with a history of substance abuse face a dramatically increased risk of death from ...
September 18, 2023 — Biosense Webster, Inc., a global leader in cardiac arrhythmia treatment and part of Johnson & ...